Coldstream Capital Management’s GSK GSK Stock Holding History

Coldstream Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$381K	Sell	7,269 -7,307	-50%	-$386K	﹤0.01%	863
2026 Q1	$806K	Buy	14,576 +1,361	+10%	+$73.8K	0.01%	524
2025 Q4	$651K	Sell	13,215 -5,954	-31%	-$278K	0.01%	605
2025 Q3	$830K	Buy	19,169 +8,926	+87%	+$349K	0.01%	521
2025 Q2	$396K	Buy	10,243 +7,797	+319%	+$298K	0.01%	757
2025 Q1	$94.8K	Buy	+2,446	New	+$89.5K	﹤0.01%	1385
2022 Q2	$204K	Buy	+3,758	New	+$207K	0.01%	729
2017 Q4	–	Sell	-4,666	Closed	-$237K	–	320
2017 Q3	$237K	Buy	+4,666	New	+$237K	0.03%	268

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Coldstream Capital Management's GSK Position: Q2 2026 in Review

Coldstream Capital Management reduced its GSK (GSK) stake by 50% in Q2 2026, selling an estimated $386K and leaving 7,269 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #863.

Coldstream Capital Management first reported a position in GSK in Q3 2017 and has held it in 8 quarters since. The position peaked at $830K in Q3 2025. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Coldstream Capital Management held 7,269 shares of GSK worth $381K as of Q2 2026.
Coldstream Capital Management sold 7,307 GSK shares in Q2 2026, an estimated $386K.
GSK made up ﹤0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #863 holding.
Coldstream Capital Management first reported a position in GSK in Q3 2017 and has held it in 8 quarters since.
Coldstream Capital Management's GSK position peaked at $830K in Q3 2025.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.